Management of Coagulase-Negative Staphylococcus Bacteremia

Diagnosis and Treatment

• The Centers for Disease Control and Prevention recommends that vancomycin therapy should not be initiated based solely on a single positive blood culture for CoNS, as this likely represents contamination and unnecessary vancomycin use promotes resistance 1, 2
• At least 2 blood cultures positive for CoNS within 48-72 hours is the minimum threshold to consider true bacteremia, according to the Infectious Diseases Society of America 3
• If only 1 of 2 blood cultures drawn simultaneously is positive for CoNS, this is highly likely contamination and vancomycin should be withheld, as recommended by the Centers for Disease Control and Prevention 1, 2
• The presence of indwelling central venous catheter or other prosthetic device is a risk factor for true CoNS bacteremia, as reported by the Infectious Diseases Society of America 4, 3
• Recent healthcare exposure, hemodialysis, chronic wounds, or long-term care facility residence are also risk factors for true CoNS bacteremia, according to the Society of Critical Care Medicine 5, 3

Antibiotic Therapy

• Vancomycin remains the appropriate empirical therapy for confirmed CoNS bacteremia, as 58-87% of CoNS isolates are methicillin-resistant, according to the Infectious Diseases Society of America 3
• Vancomycin dosing should be 40 mg/kg/day IV divided every 8-12 hours (maximum 2 g daily), as recommended by the Infectious Diseases Society of America 3
• Vancomycin covers both methicillin-susceptible and methicillin-resistant CoNS, according to the Infectious Diseases Society of America 4

Duration of Therapy

• Uncomplicated CoNS bacteremia requires 10-14 days of antimicrobial therapy if prompt clinical response and no complications, as recommended by the Infectious Diseases Society of America 4
• Complicated infection (septic thrombosis, endocarditis, osteomyelitis) requires 4-8 weeks of therapy depending on the site, according to the Infectious Diseases Society of America 4

Device Management

• Remove or replace central venous catheters and arterial lines if multiple blood cultures are positive for CoNS, as recommended by the Society of Critical Care Medicine 5, 3
• Catheter retention is associated with persistent bacteremia, according to the Infectious Diseases Society of America 4

De-escalation Strategy

• If methicillin-susceptible CoNS, consider switching from vancomycin to nafcillin, oxacillin, or cefazolin, as recommended by the Centers for Disease Control and Prevention 1, 2
• If methicillin-resistant, continue vancomycin for full treatment course, according to the Infectious Diseases Society of America 4, 3

Monitoring Requirements

• Vancomycin trough levels should be monitored, especially in patients with renal impairment, as recommended by the Infectious Diseases Society of America 3
• Target trough: 15-20 mcg/mL for serious infections, according to the Infectious Diseases Society of America 3
• Repeat blood cultures to document clearance of bacteremia, as recommended by the Infectious Diseases Society of America 4

Special Populations

• Patients with prosthetic valves or devices require a higher threshold for treating CoNS as true pathogen and longer duration of therapy (4-6 weeks), according to the Infectious Diseases Society of America 4
• Consider infectious diseases consultation for patients with prosthetic valves or devices, as recommended by the Infectious Diseases Society of America 4, 3

Coagulase-Negative Staphylococcus Bacteremia Diagnosis and Management

Clinical Risk Factors and Signs

• The presence of indwelling central venous catheters or other intravascular devices substantially increases the likelihood that CoNS represents true infection, as seen in 87.9% of true CoNS bacteremia cases, according to the American College of Radiology 6, 7
• Clinical evidence of catheter-related infection, such as exit site infection or tunnel infection, supports true infection, as recommended by the American College of Radiology 6, 7
• Persistent bacteremia despite appropriate initial management suggests true infection, as indicated by the American College of Radiology 6, 7

Special Considerations for Staphylococcus lugdunensis

• Staphylococcus lugdunensis requires management similar to S. aureus due to its high virulence and ability to cause endocarditis and metastatic infections, as stated by the European Society of Cardiology 8, 9
• At least two independent blood culture sets are necessary to differentiate contamination from true infection in cases of Staphylococcus lugdunensis, as recommended by the European Society of Cardiology 8, 9
• Consideration of echocardiography to evaluate for endocarditis is necessary in cases of Staphylococcus lugdunensis, as suggested by the European Society of Cardiology 8, 9

Assessment and Management of Staphylococcus hominis Blood Cultures

Diagnostic Criteria

Clinical Assessment

Laboratory and Collection Practices

Sampling Strategy

Guidelines for Interpreting Blood Culture Results

Definition and Core Criteria

• A blood culture isolate is deemed a true pathogen when (1) a recognized pathogen (e.g., Staphylococcus aureus, Escherichia coli, Streptococcus pneumoniae, Candida spp.) grows from a single culture, or (2) a common skin contaminant grows from ≥ 2 separate blood cultures drawn on different occasions and the patient exhibits clinical signs of infection such as fever > 38 °C, chills, or hypotension. [12][13]14

Organism Classification

• Recognized pathogens are always considered true infections even if only a single blood culture is positive. [12][13]14

Quantitative Criteria for Common Skin Contaminants

• For organisms typically regarded as skin flora, both of the following must be present to label the isolate a true pathogen:

Clinical Context Indicators

• Presence of an indwelling central venous catheter or prosthetic device markedly increases the likelihood that a skin‑flora isolate represents a true bloodstream infection. [12][13][14][15]16
• Typical clinical signs supporting a true infection include fever, chills, hypotension, rapid breathing, altered mental status, and reduced urine output. [12][13][14][15]

Catheter‑Related Bloodstream Infection (CRBSI) Diagnostic Criteria

Specimen Collection Recommendations

• Blood cultures should be obtained before initiating antimicrobial therapy to avoid false‑negative results. [15][16]

All statements are based on CDC/MMWR Recommendations and Reports (2002) and recent Clinical Infectious Diseases publications (2024).

Guidelines for Interpreting Staphylococcus epidermidis Blood Cultures

Diagnostic Criteria for True Bacteremia vs. Contamination

High‑Risk Clinical Contexts

Catheter‑Related Bloodstream Infection (CRBSI) Definition

Management Decisions Based on Culture Results

Special Populations

Neonates and Infants (< 1 year)

Pediatric Patients with Central Lines

Immunocompromised Hosts

Epidemiology